| 1 |
Pinto CJG, Ávila-Gálvez MÁ, Lian Y, Moura-Alves P, Nunes Dos Santos C. Targeting the aryl hydrocarbon receptor by gut phenolic metabolites: A strategy towards gut inflammation. Redox Biol 2023;61:102622. [PMID: 36812782 DOI: 10.1016/j.redox.2023.102622] [Reference Citation Analysis]
|
| 2 |
Wang L, Feng Z, Zheng T, Dai G, Wang M, Zhou L, Zheng Y, Chen G. Associations between the kynurenine pathway and the brain in patients with major depressive disorder-A systematic review of neuroimaging studies. Prog Neuropsychopharmacol Biol Psychiatry 2023;121:110675. [PMID: 36372294 DOI: 10.1016/j.pnpbp.2022.110675] [Reference Citation Analysis]
|
| 3 |
Farup PG, Hamarsland H, Mølmen KS, Ellefsen S, Hestad K. The Kynurenine Pathway in Healthy Subjects and Subjects with Obesity, Depression and Chronic Obstructive Pulmonary Disease. Pharmaceuticals 2023;16:351. [DOI: 10.3390/ph16030351] [Reference Citation Analysis]
|
| 4 |
Salminen A. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota. J Mol Med (Berl) 2023. [PMID: 36757399 DOI: 10.1007/s00109-023-02289-5] [Reference Citation Analysis]
|
| 5 |
Puccetti M, Pariano M, Wojtylo P, Schoubben A, Giovagnoli S, Ricci M. Turning Microbial AhR Agonists into Therapeutic Agents via Drug Delivery Systems. Pharmaceutics 2023;15. [PMID: 36839828 DOI: 10.3390/pharmaceutics15020506] [Reference Citation Analysis]
|
| 6 |
Kozieł K, Urbanska EM. Kynurenine Pathway in Diabetes Mellitus-Novel Pharmacological Target? Cells 2023;12. [PMID: 36766803 DOI: 10.3390/cells12030460] [Reference Citation Analysis]
|
| 7 |
Biswas P, Stuehr DJ. Indoleamine Dioxygenase and Tryptophan Dioxygenase Activities are Regulated through Control of Cell Heme Allocation by Nitric Oxide.. [DOI: 10.1101/2022.12.30.522347] [Reference Citation Analysis]
|
| 8 |
Ren R, Fang Y, Sherchan P, Lu Q, Lenahan C, Zhang JH, Zhang J, Tang J. Kynurenine/Aryl Hydrocarbon Receptor Modulates Mitochondria-Mediated Oxidative Stress and Neuronal Apoptosis in Experimental Intracerebral Hemorrhage. Antioxid Redox Signal 2022;37:1111-29. [PMID: 35481813 DOI: 10.1089/ars.2021.0215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Hu Y, Liu Z, Tang H. Tryptophan 2,3-dioxygenase may be a potential prognostic biomarker and immunotherapy target in cancer: A meta-analysis and bioinformatics analysis. Front Oncol 2022;12:977640. [DOI: 10.3389/fonc.2022.977640] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 10 |
Qian M, Xia Y, Zhang G, Yu H, Cui Y. Research progress on microRNA-1258 in the development of human cancer. Front Oncol 2022;12:1024234. [PMID: 36249037 DOI: 10.3389/fonc.2022.1024234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Chiu LC, Tang HY, Fan CM, Lo CJ, Hu HC, Kao KC, Cheng ML. Kynurenine Pathway of Tryptophan Metabolism Is Associated with Hospital Mortality in Patients with Acute Respiratory Distress Syndrome: A Prospective Cohort Study. Antioxidants (Basel) 2022;11. [PMID: 36290606 DOI: 10.3390/antiox11101884] [Reference Citation Analysis]
|
| 12 |
Li D, Yu S, Long Y, Shi A, Deng J, Ma Y, Wen J, Li X, Liu S, Zhang Y, Wan J, Li N, Ao R. Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders. Front Immunol 2022;13:985378. [DOI: 10.3389/fimmu.2022.985378] [Reference Citation Analysis]
|
| 13 |
Wang B, Zhou Z, Li L. Gut Microbiota Regulation of AHR Signaling in Liver Disease. Biomolecules 2022;12:1244. [DOI: 10.3390/biom12091244] [Reference Citation Analysis]
|
| 14 |
Sathyasaikumar KV, Notarangelo FM, Kelly DL, Rowland LM, Hare SM, Chen S, Mo C, Buchanan RW, Schwarcz R. Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid. Pharmaceuticals (Basel) 2022;15. [PMID: 36015151 DOI: 10.3390/ph15081003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Nkandeu DS, Basson C, Joubert AM, Serem JC, Bipath P, Nyakudya T, Hlophe Y. The involvement of a chemokine receptor antagonist CTCE-9908 and kynurenine metabolites in cancer development. Cell Biochem Funct 2022. [PMID: 35789495 DOI: 10.1002/cbf.3731] [Reference Citation Analysis]
|
| 16 |
Chilosi M, Doglioni C, Ravaglia C, Martignoni G, Salvagno GL, Pizzolo G, Bronte V, Poletti V. Unbalanced IDO1/IDO2 Endothelial Expression and Skewed Keynurenine Pathway in the Pathogenesis of COVID-19 and Post-COVID-19 Pneumonia. Biomedicines 2022;10:1332. [DOI: 10.3390/biomedicines10061332] [Reference Citation Analysis]
|
| 17 |
Teunis C, Nieuwdorp M, Hanssen N. Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases. Metabolites 2022;12:514. [DOI: 10.3390/metabo12060514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 18 |
Sadok I, Jędruchniewicz K, Staniszewska M. Quantification of nicotinic acid, kynurenine, and kynurenine acid in poultry meat by validated liquid chromatography-single quadrupole mass spectrometry method. LWT 2022;163:113582. [DOI: 10.1016/j.lwt.2022.113582] [Reference Citation Analysis]
|
| 19 |
Fan Q, Zuo J, Tian H, Huang C, Nice EC, Shi Z, Kong Q. Nanoengineering a metal-organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells. J Exp Clin Cancer Res 2022;41:162. [PMID: 35501823 DOI: 10.1186/s13046-022-02372-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Marszalek-Grabska M, Stachniuk A, Iwaniak P, Gawel K, Sumara A, Kocki T, Fornal E, Milart P, Paluszkiewicz P, Turski W. Unexpected content of kynurenine in mother's milk and infant formulas. Sci Rep 2022;12:6464. [PMID: 35440600 DOI: 10.1038/s41598-022-10075-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Salminen A. Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process. Ageing Res Rev 2022;75:101573. [PMID: 35085834 DOI: 10.1016/j.arr.2022.101573] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 22 |
Russo F, Tolomeo F, Vandelli MA, Biagini G, Paris R, Fulvio F, Laganà A, Capriotti AL, Carbone L, Gigli G, Cannazza G, Citti C. Kynurenine and kynurenic acid: Two human neuromodulators found in Cannabis sativa L. Journal of Pharmaceutical and Biomedical Analysis 2022;211:114636. [DOI: 10.1016/j.jpba.2022.114636] [Reference Citation Analysis]
|
| 23 |
Biswas P, Dai Y, Stuehr DJ. Indoleamine dioxygenase and tryptophan dioxygenase activities are regulated through GAPDH- and Hsp90-dependent control of their heme levels. Free Radic Biol Med 2022:S0891-5849(22)00019-3. [PMID: 35051612 DOI: 10.1016/j.freeradbiomed.2022.01.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Shen CL, Mo H, Dunn DM, Watkins BA. Tocotrienol Supplementation Led to Higher Serum Levels of Lysophospholipids but Lower Acylcarnitines in Postmenopausal Women: A Randomized Double-Blinded Placebo-Controlled Clinical Trial. Front Nutr 2021;8:766711. [PMID: 35004805 DOI: 10.3389/fnut.2021.766711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Dogrul BN. Indolamine 2,3-dioxygenase (IDO) inhibitors as a potential treatment for somatic symptoms. Medical Hypotheses 2022. [DOI: 10.1016/j.mehy.2022.110777] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 26 |
Xu L, Ling J, Su C, Su YW, Xu Y, Jiang Z. Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries. Front Med (Lausanne) 2021;8:756435. [PMID: 34869457 DOI: 10.3389/fmed.2021.756435] [Reference Citation Analysis]
|
| 27 |
Ferreira Branquinho MS, Silva MBB, Castilho GA, Cavalcante J, Barros SBM, Clara RO, Maria-Engler SS, Campa A. Kynurenine inhibits melanogenesis in human melanocyte-keratinocyte co-cultures and in a reconstructed 3D skin model. Exp Dermatol 2021. [PMID: 34710259 DOI: 10.1111/exd.14486] [Reference Citation Analysis]
|
| 28 |
Sadok I, Staniszewska M. Electrochemical Determination of Kynurenine Pathway Metabolites-Challenges and Perspectives. Sensors (Basel) 2021;21:7152. [PMID: 34770460 DOI: 10.3390/s21217152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 29 |
Joisten N, Ruas JL, Braidy N, Guillemin GJ, Zimmer P. The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force? Trends Mol Med 2021:S1471-4914(21)00187-8. [PMID: 34373202 DOI: 10.1016/j.molmed.2021.07.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 30 |
Eryavuz Onmaz D, Sivrikaya A, Isik K, Abusoglu S, Albayrak Gezer I, Humeyra Yerlikaya F, Abusoglu G, Unlu A, Tezcan D. Altered kynurenine pathway metabolism in patients with ankylosing spondylitis. Int Immunopharmacol 2021;99:108018. [PMID: 34358860 DOI: 10.1016/j.intimp.2021.108018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
